SCHEMBL3603427

SCHEMBL3603427

O=C(O)c1cc(-c2nnn[nH]2)c(-c2cccc3ccccc23)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.41
ACMSD Q8TDX5 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NOTUM Q6P988 5/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
LMNA P02545 1/20 0.38
BCL2L1 Q07817 1/20 0.37
PLK4 O00444 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
CHEK2 O96017 1/20 0.36
CDK1 P06493 1/20 0.36
PIM1 P11309 1/20 0.36
PRKACA P17612 1/20 0.36
CDK2 P24941 1/20 0.36
MAPK9 P45984 1/20 0.36
CSNK1D P48730 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596652 0.83 NOTUM (0.42) ACMSDNOTUMKDM4EALDH1A1HPGD
SCHEMBL3606403 0.82 MAPK14 (0.46) MEN1KMT2ANOTUMKDM4EALDH1A1
SCHEMBL3328685 0.81 KMT2A (0.35) MCL1ACMSDMEN1KMT2AKDM4E
SCHEMBL3328679 0.81 KMT2A (0.35) MCL1ACMSDMEN1KMT2AKDM4E
SCHEMBL3602742 0.81 KDM4E (0.41) MEN1KMT2ANOTUMKDM4EALDH1A1
SCHEMBL3611041 0.78 KDM4E (0.46) KMT2ANOTUMKDM4EALDH1A1HPGD
SCHEMBL3592626 0.78 CSNK1D (0.47) NOTUMKDM4EPLK4AURKADAPK3
SCHEMBL1250423 0.76 KDM4E (0.42) KDM4EALDH1A1HPGDGSK3BGAA
SCHEMBL3325817 0.76 CCNC (0.38) KMT2AKDM4EALDH1A1HPGDLMNA
SCHEMBL3325821 0.76 CCNC (0.38) KMT2AKDM4EALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UNIBIOSCREEN SA (BE) 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 MCL1 2400/4885ACMSD 1504/4885MEN1 4677/4885
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES MIF, IMPDH1, IMPDH2 MCL1 630/4885ACMSD 1111/4885MEN1 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.